HERBERT J. SEMLER, M.S., M.D.
F.A.C.P., F.A.C.C., F.S.C.A.I., F.A.H.A.
Clinical Professor Cardiovascular Medicine
Oregon Health and Science University
Meet Dr. Herb Semler, M.D., the founder of Dr. Semler’s HeartPerks and Dr. Semler’s HeartPerks App. He is a respected, internationally known cardiologist and inventor who holds multiple patents for cardiovascular products. He has taught and practiced cardiology for more than 50 years.
Dr. Semler’s HeartPerks, Inc. (SHP) was founded in 2014 upon decades of experience providing the highest level of cardiovascular care to patients. SHP is a preventative health care company fully dedicated to making a difference in the lives of people by providing motivation so you can reduce the risks of having a heart attack or stroke, the #1 cause of death in America among men and women.
Dr. Semler was a Clinical Professor of Cardiovascular Medicine at Oregon Health Sciences University. He was a senior consultant to the Board of the American College of Cardiology, and since 1965 he has served as a Fellow of the American College of Physicians, the American College of Cardiology, and the American Heart Association Council on Cardiology. He earned his M.D. at Oregon Health Sciences University in Portland, Oregon, and his Master of Sciences Degree in Pharmacology, also at OHSU. Dr. Semler was awarded a Fellowship in Internal Medicine and a Fellowship in Cardiovascular Physiology at the Mayo Clinic. He has served as a Cardiology Consultant at the Mayo Clinic, and is certified by the American Board of Internal Medicine and the American Board of Cardiovascular Diseases.
Dr. Semler founded Instromedix, Inc., a medical equipment company he sold in 1998. He then founded Advanced Vascular Dynamics and developed patented products for arterial hemostasis (controlling blood flow). Dr. Semler invented FloChec®, a device which assesses risk profile in patients by determining their vascular condition. Semler Scientific (SMLR: OTC) an emerging medical risk-assessment company was founded by Dr. Semler in 2007 and went public in early 2014.